CARsgen's BCMA CAR T moving to clinic in China

CARsgen said CT053 (CAR-BCMA) received IND clearance from China's National Medical Products Administration (NMPA).

CARsgen Therapeutics Co. Ltd. (Shanghai, China) said it is also planning to submit this year an IND to FDA for the product...